Organon
Organon offers a diverse portfolio of women's health products and biosimilars, operating in over 140 markets worldwide. The company has received multiple recognitions for its contributions to gender equity, diversity inclusion, and expanding global access to contraceptives.
Women's Health Products at Organon
Organon specializes in a portfolio of products tailored for women's health. These products address a range of needs including contraception, fertility, maternal and peripartum conditions, and conditions that are unique to or more common in women. This focus underlines Organon's commitment to enhancing healthcare specifically for women, making it a key player in this critical area of medical health.
Organon's Biosimilars
Organon provides biosimilars as part of its strategy to increase the accessibility of treatment options. Biosimilars offer alternative options to existing biologic treatments and aim to be cost-effective solutions, benefiting patients, healthcare providers, and systems globally. This aligns with Organon’s mission to improve health outcomes and access to essential medicines.
Established Brands and Therapeutic Areas
In addition to its focus on women’s health, Organon has established brands in several therapeutic areas. These areas include cardiovascular disease, respiratory conditions, dermatology, central nervous system disorders, bone health, immunology, non-opioid pain management, and menopause. This diverse range of therapeutic specializations allows Organon to address a broad spectrum of medical needs in the healthcare market.
Global Reach and Market Presence
Organon operates in more than 140 markets worldwide, demonstrating a significant global footprint. This extensive reach enables the company to impact a wide range of healthcare markets, promoting access to their specialized products and treatments on an international scale.
Awards and Recognition
Organon has received several accolades acknowledging its contributions and initiatives. It is recognized in JUST Capital's America’s Most JUST Companies, JUST 100 Index for 2024. Organon was listed in Fortune's Change the World 2023 for expanding global access to contraceptives. Additionally, the company was awarded by She Is Global Forum as Organization of the Year for generating change towards gender equity in 2023. In the same year, Organon was also named a Best Place to Work for Diversity Inclusion by the Disability Equality Index.